SCHEMBL7334094

SCHEMBL7334094

CC(C)NC(=O)Nc1ccc2cc(C#N)ccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 2/20 0.57
F2 P00734 1/20 0.57
PLG P00747 1/20 0.57
KLKB1 P03952 1/20 0.57
PRSS1 P07477 1/20 0.57
MAPT P10636 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 2/20 0.51
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
TBXA2R P21731 8/20 0.47
LMNA P02545 3/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47
IL18 Q14116 1/20 0.47
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12890539 0.85 MAPT (0.60) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL7344351 0.84 PLAU (0.61) PLAUF2PLGKLKB1PRSS1
SCHEMBL12890530 0.82 KMT2A (0.66) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL19020205 0.80 RAB9A (0.65) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL7343218 0.79 PLAU (0.72) PLAUF2PLGKLKB1PRSS1
SCHEMBL7336127 0.76 EPHX1 (0.76) MEN1KMT2AALDH1A1RAB9ANPC1
SCHEMBL25901051 0.75 CA2 (0.46) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL18580763 0.74 DYRK1A (0.48) MAPTMEN1KMT2ARAB9ANPC1
SCHEMBL13449739 0.74 CA12 (0.70) MEN1KMT2AALDH1A1RAB9ALMNA
SCHEMBL3557455 0.73 PLAU (0.56) PLAUF2PLGKLKB1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed
EP-1000018-A2 UROKINASE INHIBITORS Abbott Laboratories (US) 2000-05-17 EP disclosed
WO-1999005096-A2 UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 1999-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 PLAU 2/4885F2 38/4885PLG 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.